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a b s t r a c t
The placenta plays a critical role in the growth and survival of the fetus. Here we demonstrate that the
Homologous to the E6-AP Carboxyl Terminus (HECT) domain E3 ubiquitin ligase, Hectd1, is essential for
development of the mouse placenta. Hectd1 is widely expressed during placentation with enrichment in
trophoblast giant cells (TGCs) and other trophoblast-derived cell subtypes in the junctional and labyrinth
zones of the placenta. Disruption of Hectd1 results in mid-gestation lethality and intrauterine growth
restriction (IUGR). Variable defects in the gross structure of the mutant placenta are found including
alterations in diameter, thickness and lamination. The number and nuclear size of TGCs is reduced.
Examination of subtype speciﬁc markers reveals altered TGC development with decreased expression of
Placental lactogen-1 and -2 (Pl1 and Pl2) and increased expression of Proliferin (Plf). Reduced numbers of
spongiotrophoblasts and glycogen trophoblasts were also found at the junctional zone of the Hectd1
mutant placenta. Finally, there was an increase in immature uterine natural killer (uNK) cells in the
maternal decidua of the Hectd1 mutant placenta. Proliferation and apoptosis are differentially altered in
the layers of the placenta with an increase in both apoptosis and proliferation in the maternal decidua, a
decrease in proliferation and increase in apoptosis in the labyrinth layer and both unchanged in the
junctional zone. Together these data demonstrate that Hectd1 is required for development of multiple
cell types within the junctional zone of the placenta.
& 2014 Published by Elsevier Inc.
Introduction
Development and survival of the mammalian embryo depends on
the placenta, which is responsible for the exchange of nutrients and
gases, removal of embryonic waste and secretion of hormones
(Rossant and Cross, 2001). Abnormal placental development underlies
awide range of complications during pregnancy including intrauterine
growth restriction (IUGR), preeclampsia andmiscarriage, and has been
implicated in predisposition to chronic diseases in adulthood (Cross,
2006; Fowden et al., 2008; Longtine and Nelson, 2011). Many
similarities exist between the mouse and human placenta making
the mouse an excellent model to elucidate the mechanisms of
placental development in humans (Georgiades et al., 2002;
Malassine et al., 2003). Mouse models have become indispensable
for deﬁning cell types, lineage relationships and molecular pathways
required for normal placentation (Cross, 2005; Rossant and Cross,
2001).
The mature mouse placenta is a layered structure comprised of
cells derived from both the conceptus (trophoectoderm and extra-
embryonic mesoderm) and the maternal decidua (Rossant and Cross,
2001). Closest to the umbilical cord that connects the placenta to the
embryo is the labyrinth zone, which consists of fetal and maternal
blood spaces separated by vascular endothelium and specialized
trophoblast cell types. The labyrinth zone provides the interface for
exchange between maternal and fetal circulations. The junctional
zone separates the labyrinth from the maternal decidua and consists
of spongiotrophoblasts, glycogen trophoblasts and a discontinuous
layer of trophoblast giant cells (TGCs) with large polyploid nuclei.
TGCs are the main endocrine cells of the placenta secreting a number
of hormones necessary for modulating maternal physiology and
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placental development (Malassine et al., 2003). While spongiotro-
phoblasts and glycogen trophoblasts are essential for normal func-
tion of the placenta, their speciﬁc function remains unknown.
Uterine natural killer (uNK) cells are recruited to the implantation
site and interact with trophoblasts inﬂuencing their invasion into the
maternal decidua (Bilinski et al., 2008; Croy et al., 2003). Together
uNK and trophoblast cells remodel spiral arteries to increase mater-
nal blood ﬂow to the placenta (Harris, 2010; Wallace et al., 2012).
Hectd1 is a HECT domain E3 ubiquitin ligase that plays an
important role in development of the neural tube (Sarkar and
Zohn, 2012; Zohn et al., 2007) and regulation of Wnt signaling
(Tran et al., 2013). Ubiquitin conjugated substrates are widely
distributed in the endometrium and decidua in rodents and
primates (Bebington et al., 2000), and studies of mouse mutants
demonstrate that ubiquitin dependent modiﬁcation plays an
indispensable role in placental development. For example, muta-
tion of mouse Cul4B, an E3 ligase of the cullin ring family results in
an abnormal placenta and early embryonic lethality (Jiang et al.,
2012). Here we demonstrate that homozygous Hectd1 mutant
embryos exhibit midgestation lethality and growth deﬁciencies
associated with defects in placental development. Our data indi-
cate Hectd1 is transcribed and translated in multiple trophoblast-
derived cell types throughout placental development. Loss of
Hectd1 function results in altered placenta architecture, apoptosis
and proliferation. Furthermore, the number, size and/or distribu-
tion of TGCs, spongiotrophoblasts, glycogen trophoblasts and uNK
cells are affected in homozygous Hectd1 mutant placentas.
Materials and methods
Mouse breeding and placental tissue collection
The Hectd1opm and Hectd1Gt(XC266)Byg (Hectd1XC) mouse lines used in
this study have been previously described (Kasarskis et al., 1998; Zohn
et al., 2007). All experiments were done on congenic 129S1/SvImJ.
C57Bl/6-Hectd1opm or 129S1/SvImJ.129P2/OlaHsd-Hectd1XC back-
grounds. For phenotypic analysis Hectd1opm/þ mice were intercrossed
and placentas collected at the indicated developmental stages.
Hectd1XC/þ mice were also intercrossed for determination of Mende-
lian ratios of survival and expression analysis. Heterozygous Hectd1XC
mice were also bred to wildtype mice for analysis of Hectd1 expres-
sion. Only placentas serving live embryos were analyzed. Placentas
were ﬁxed by immersion in 4% paraformaldehyde ﬁxative for 24 h,
embedded in Optimal Cutting Temperature compound (OCT, Tissue-
Tek) and serial 10 mm sections cut using a cryostat. Genotyping was
performed using the yolk sac as described (Sarkar and Zohn, 2012).
Phenotypic and histological analyses
Embryos were weighed on a chemical balance and placental
diameters measured using a dissecting scope with the aid of a
graduated slide. The size of TGC nuclei was measured using ImageJ
software. To assess placental thickness and histology, sections were
stained with hematoxylin and eosin (H&E). To analyze Hectd1
expression, sectioned Hectd1XC/þ conceptuses or isolated placentas
were subjected to LacZ staining and counterstained with eosin (Nagy,
2003). In situ hybridization on sectioned placentas was carried out as
described (Zohn et al., 2006) and counterstained with eosin. The
following probes were used: Hand1 (Scott et al., 2000), Prl3d1/Pl1
(Faria et al., 1991), Prl3b1/Pl2 (Jackson et al., 1986), Prl2c2/Plf (Linzer et
al., 1985), Tpbpa (Carney et al., 1993), Cdx2 (Strumpf et al., 2005) and
Mash2 (Guillemot et al., 1994). Immunoﬂuorescence and immuno-
histochemical analyses were performed as described (Sarkar and
Zohn, 2012) using the following antibodies: Hectd1 (Novus Biologi-
cals, #H00025831-M03), Pecam1 (Becton-Dickinson, #550274), FK2
(mono- and polyubiquitin; Biomol, #PW0150-0100), Cdx2 (Cell
Signaling, #3977), Cleaved caspase-3 (CC3; Cell Signaling, #9661),
Phospho-Histone H3 (PH3; Cell Signaling, #9713) and Perforin (Cell
Signaling, #3693). In immunoﬂuorescence experiments, nuclei were
stained with Hoechst (Promega, P5541). To stain glycogen-containing
cells, a Periodic Acid-Schiff (PAS) staining kit (Polyscience Inc.,
#24200) was used. Glycogen content of placentas was determined
as described (Tesser et al., 2010). Stereological analyses were per-
formed essentially as described (Coan et al., 2004) using the Stereo
Investigator software system (MBF Biosciences, Vermont, USA).
Western blotting and quantitative PCR (qPCR) analyses
Placentas and tissue fragments were collected from time-mated
adult female mice and analyzed by western blotting with anti-
Hectd1 (Novus Biologicals, #H00025831-M03) and anti-GAPDH
(Cell Signaling, #2118) antibodies. For determination of ubiquiti-
nated proteins in wildtype and mutant placentas, Hectd1opm mice
were intercrossed and placentas dissected at E12.5. Ubiquitinated-
proteins were enriched from whole placenta extracts using the
ubiquitin protein enrichment kit (EMD-Millipore, #662200) then
visualized by immunoblotting with the FK2 antibody (Biomol,
#PW0150-0100). qRT-PCR on E10.5 placentas was performed as
described (Maynard et al., 2013) using primers listed in Parast et al.
(2009). All statistical analyses were performed using Microsoft
Excel software. Student's t-test with Bonferroni correction was used
to determine statistical signiﬁcance between groups.
Results
Mutation of Hectd1 disrupts placental development
Two Hectd1 mutant mouse lines were used for these studies:
Hectd1opm and Hectd1Gt(XC266)Byg (Hectd1XC). Hectd1opm is an N-ethyl-
N-nitrosourea (ENU) induced allele and contains a missense muta-
tion that results in truncation of the 2611 amino acid Hectd1 protein
after amino acid 144 (Zohn et al., 2007). This results in an effectively
null allele as all protein–protein interaction and catalytic domains are
deleted. The Hectd1XC allele contains a genetrap insertion disrupting
the C-terminal HECT domain and the ubiquitin ligase activity of the
protein. The mutant protein is expressed and other protein–protein
interaction domains of the protein remain intact (Sarkar and Zohn,
2012; Zohn et al., 2007). Hectd1opm and Hectd1XC fail to complement
each other and exhibit identical phenotypes with regard to neural
tube closure (Zohn et al., 2007). Homozygous Hectd1opm and Hectd1XC
mutant embryos begin to die after E12.5 and expected Mendelian
ratios of mutants are not found from E13.5 to E18.5 (Table 1). This
mid-gestation lethality is not due to the neural tube defect, as
exencephaly is not fatal until after birth (Copp et al., 2003). Homo-
zygous Hectd1opm mutant embryos that survive to E13.5 are pale,
developmentally delayed and occasionally exhibit edema (data not
shown). Furthermore, the weight of Hectd1opm mutant embryos at
E11.5 and E12.5 is signiﬁcantly reduced (Fig. 1A).
Mid-gestation lethality is associated with abnormal develop-
ment of multiple organ systems including the placenta. Since our
previous studies demonstrate Hectd1 expression in the E12.5
placenta (Zohn et al., 2007), we analyzed the Hectd1opm mutant
placenta for developmental defects to determine if placental
defects possibly contribute to mid-gestation lethality. Hectd1opm
mutant placentas exhibit a spectrum of phenotypic severities
ranging from no apparent phenotype to a placenta that is severely
reduced in diameter and thickness and does not show clear
lamination (Fig. 1D–I and Supplemental Fig. 1). To quantify the
effect of Hectd1 mutation on placental development, placental
diameter and thickness were measured in wildtype and Hectd1
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mutant placentas between ages E10.5 and E13.5. At E13.5, but not
earlier, the diameter of Hectd1opm homozygous mutant placentas is
signiﬁcantly smaller than sibling controls (Fig. 1B) and thickness is
reduced from E10.5 through E13.5 (Fig. 1C). To quantify phenotypic
variability, we scored for the incidence of six factors in 123 mutant
placentas: growth restriction of the embryo (31.7% of mutant
placentas showed this phenotype) and placental hemorrhage
(47.9%), paleness (Fig. 1J and K; 30.9%), reduced diameter (43.1%),
thickness (66.7%) and weight (69.1%). A severe phenotype (all
6 parameters present) was found in 8% and no apparent pheno-
type in 10% of the Hectd1opm mutant placentas examined
(Supplemental Fig. 1). All subsequent analyses focused on the
majority (82%) of cases that exhibited a moderate phenotype with
between one and ﬁve of these defects. This variable penetrance
and expressivity of placenta defects is very common in mouse
mutants (see Barak et al., 2002; Caspary et al., 1999; Catela et al.,
2009; Eggenschwiler et al., 1997 for examples).
Hematoxylin and eosin (H&E) staining was used to examine the
tissue architecture of Hectd1opm mutant placentas (Fig. 1D–I).
Analysis of mutant placentas reveals larger tissue spaces in
all layers compared to the wildtype (n¼34; labeled with * in
Fig. 1G–I). In roughly half of the mutant placentas, trophoblast
layers were reduced and the maternal decidua was correspond-
ingly enlarged in thickness. To quantify differences in placental
structures, a stereological analysis was undertaken on three
moderately affected E13.5 placentas. A signiﬁcant reduction in
the labyrinth zone volume was observed in mutants to 41% of the
wildtype volume (5176 mm3; mutant¼2172 mm3; p¼0.042).
The maternal decidual volume was increased 44% in the mutant
(wild type ¼ 1873 mm3; mutant¼2673 mm3; p¼0.023), while
the junctional zone volume was not signiﬁcantly different
between wildtype (2472 mm3) and mutant (1774 mm3;
p¼0.61). The number and nuclear size of TGCs in the junctional
zone were also signiﬁcantly reduced (Fig. 1L and M). Taken
together, these results demonstrate that the Hectd1 mutant
placenta exhibits a range of structural abnormalities.
Hectd1 is expressed in multiple cell types during development of the
placenta
To better understand the role of Hectd1 in placentation, the
spatiotemporal expression pattern of Hectd1 between E7.5 and
13.5 was examined in detail (Figs. 2, 3 and Table 2). To examine
expression of the Hectd1 transcript, expression of beta-
galactosidase was determined by LacZ staining in the heterozy-
gous Hectd1XC/þ genetrap conceptus (Zohn et al., 2007). Samples
from crosses between wildtype females and Hectd1XC/þ males
were used to label Hectd1 expressing cells derived from the
conceptus and not the maternal decidua. At E7.5, the implantation
site is lined by primary and secondary TGCs that arise from the
mural and polar trophectoderm, respectively. The polar trophec-
toderm contributes to the extra-embryonic ectoderm (ExE) and
contains pluripotent trophoblast stem cells that differentiate into
the different trophoblast cell types that will make up the chor-
ioallantoic placenta. The ExE develops into the chorion and the
ectoplacental cone (EPC), which gives rise to trophoblast cells that
populate the labyrinth and junctional zones, respectively. The EPC
also contributes secondary TGCs that invade the maternal uterine
wall to promote decidualization. Hectd1 is expressed in the
primary and secondary TGCs, chorion and EPC at E7.5 (Fig. 2A
and B). By E8.5, Hectd1 expression intensiﬁes in the chorion and
scattered TGCs in the EPC (Fig. 2C and D). In the E9.5 conceptus,
the allantois has fused with the chorion and chorionic villi have
begun to undergo branching morphogenesis. Allantoic mesoderm-
derived fetal vessels invade the branching villi to form the fetal
vasculature. The EPC has expanded and ﬂattened to form the
spongiotrophoblast layer of the junctional zone. TGCs further
invade the maternal decidua and around the maternal spiral
arteries. Hectd1 is expressed in all of these cell types with higher
levels in trophoblasts at the border of the allantoic mesoderm
(arrows in Fig. 2F) and scattered trophoblasts within the junctional
and labyrinth zones (arrowheads in Fig. 2F). Between E9.5 and 13.5
Hectd1 expression becomes progressively reduced in cells of the
allantoic mesoderm, compared to the trophoblast layers (Fig. 2G–
N). During these stages, Hectd1 continues to be expressed at
higher levels in labyrinth trophoblasts at the junction of the
chorion and allantoic mesoderm (arrows in Fig. 2G and data not
shown). By E13.5, these cells will develop into labyrinth tropho-
blasts that separate fetal and maternal blood spaces that express
high level of Hectd1 including syncytiotrophoblasts (long ﬂat cells)
and sinusoidal trophoblast giant cells (Fig. 2N; arrows). In addi-
tion, scattered clusters of cells in the junctional zone show high
levels of Hectd1 expression (arrowheads in Fig. 2G–L). To compare
expression of Hectd1 in the maternal decidua versus trophoblast
and inner cell mass-derived lineages, heterozygous Hectd1XC mice
were intercrossed and expression analyzed in heterozygous E13.5
Hectd1XC/þ placentas. Hectd1 is expressed at greater intensity in
the maternal decidua and cells that separate maternal and fetal
circulations in the labyrinth zone than in other cells derived from
the conceptus (Fig. 2M and N).
Hectd1 protein is expressed in the E12.5 placenta (Fig. 3A).
Additionally, in the adult female mouse, Hectd1 protein is present
in speciﬁc regions of the brain with minimal expression in the
spinal cord, kidneys and liver (Fig. 3A). Immunohistochemical
analysis was used to determine the spatial expression of Hectd1
protein in the E12.5 placenta. Hectd1 protein is widely expressed
with higher levels in certain cell types (Fig. 3B, D, and E); but
unlike the transcript, relatively equivalent levels are found in the
maternal decidua and junctional and labyrinth zones. Scattered
trophoblasts in the junctional zone express high levels of Hectd1
(arrowheads in Fig. 3D). In the labyrinth zone, Hectd1 protein is
highly expressed in trophoblasts bordering the allantoic meso-
derm (arrow in Fig. 3E) and at low levels in the allantoic
mesoderm itself (AL in Fig. 3E). Hectd1 is also expressed in
endothelial cells lining fetal blood vessels, as it colocalizes with
Pecam1 (Fig. 3F–I). As a negative control, the antibody was tested
on homozygous mutant Hectd1opm placentas, since the antibody
does not recognize the truncated Hectd1opm mutant protein
(Sarkar and Zohn, 2012; Fig. 3C).
Table 1
Distribution of genotypes from Hectd1 heterozygous crosses (NS ¼ not signiﬁcant).
Hectd1opm/þ Hectd1opm/þ þ /þ þ /opm opm/opm χ2 (df¼1) p
E18.5 7 29 1 9.835 o0.0025
E17.5 14 33 1 13.564 o0.0005
E16.5 17 31 2 8.82 o0.005
E15.5 47 63 3 22.568 o0.0005
E14.5 12 46 10 2.882 o0.1(NS)
E13.5 35 33 10 4.628 o0.05
Total (394) 132 235 27 51.901 o0.0005
Actual % 33.5 59.64 6.85
Expected % 25 50 25
Hectd1XC/þ Hectd1XC/þ þ /þ XC/þ XC/XC χ2 (df¼1) p
E18.5 9 17 1 7.25 o0.01
E17.5 7 18 0 6.25 o0.02
E16.5 22 25 0 11.75 o0.001
E15.5 26 55 2 16.94 o0.0005
E14.5 14 48 2 15.06 o0.0005
E13.5 23 43 2 15.01 o0.0005
Total (314) 101 206 7 65.124 o0.0005
Actual % 32.71 65.60 2.23
Expected % 25 50 25
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Our previous studies reported a decrease in total ubiquitin
conjugated proteins in Hectd1 mutant embryos (Sarkar and Zohn,
2012), thus we expected that total ubiquitin labeling in the placenta
might be similarly reduced. However, detection of total mono- and
polyubiquitin conjugated protein using the FK2 antibody by immu-
nohistochemistry showed no obvious difference between wildtype
and mutant placentas (Supplementary Fig. 2A and B). Furthermore,
the total amount of ubiquitin conjugated protein was unchanged
between wildtype and Hectd1opm mutant placental lysates in bio-
chemical pull down assays (Supplementary Fig. 2C). Interestingly, in
the wildtype placenta, ubiquitin conjugates were enriched in cells
that line maternal blood spaces in the labyrinth zone (Fig. 3J–M).
In particular, ubiquitin was concentrated in projections from these
cells. However, in mutant placentas, FK2 immunoreactivity was
reduced in cells lining blood spaces and their projections. Quantita-
tion reveals signiﬁcant differences. In wildtype placentas, the average
sinusoid had on average 26.774 ubiquitin-positive projections,
whereas Hectd1 mutants had only 2.672 ubiquitin-positive projec-
tions per sinusoid (p¼0.013). Thus, while loss of Hectd1 function
does not signiﬁcantly alter total ubiquitin levels in the placenta,
differences in ubiquitin conjugated proteins are found in cells lining
maternal blood spaces.
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Fig. 1. Mutation of Hectd1 disrupts placental development: (A) weight of Hectd1opm/opm mutant embryos (white bar) is signiﬁcantly reduced at E11.5 and E12.5 compared to
littermate controls (Hectd1þ /þ; black bar; n¼15 at each stage). (B) Placental diameter is signiﬁcantly reduced at E13.5 but not from E10.5 to E12.5 in Hectd1opm mutant
placentas. Ten wildtype and mutant placentas were analyzed at each stage. NS¼not signiﬁcant. (C) Placental thickness is signiﬁcantly reduced in Hectd1opm mutant placentas
from E10.5 to E13.5 (n¼10 at each stage). (D–I) H&E stained E12.5 wildtype (þ /þ; D–F) and moderately affected Hectd1opm mutant (opm/opm; G–I) placentas. The layers of
the placental architecture are labeled: maternal decidua (MD), junctional zone (JZ) and labyrinth zone (LZ). Higher magniﬁcation images of boxed regions are shown as
indicated. Note the larger tissues spaces (red *) and reduced lamination of the mutant placenta (n¼34). A few of the many TGCs are labeled with yellow arrowheads. Also,
note that the size of TGC nuclei appears smaller in the mutant. (J, K) Whole placentas imaged from the embryonic side reveal paleness of the mutant (opm/opm; K) placenta
versus wildtype (þ/þ; J) that was observed in 60% of 123 mutant placentas examined. (L, M) Quantiﬁcation of the number of TGCs per 100 μm2 ﬁeld (L) and TGC nuclear area
(M) in the junctional zone of wildtype and mutant placentas. The number of cells in 10 ﬁelds or the size of 10 nuclei, respectively, were counted in 3 placentas. Data represent
mean values and error bars, standard error of the mean (SEM).
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The Hectd1 mutant placenta shows altered TGC development
Defects in development of the Hectd1 mutant placenta may be
caused by altered development and/or differentiation of the
trophoblast lineage. To address this possibility, expression of a
number of trophoblast cell markers was examined in Hectd1
mutant placentas (Figs. 4 and 5 and summarized in Table 3).
Hand1 is expressed in all trophoblasts at E10.5 and is required for
the differentiation of TGC subtypes (Riley et al., 1998). At E12.5,
Hand1 is expressed in trophoblasts of the junctional and labyrinth
zones (Scott et al., 2000). Analysis of Hand1 expression in E10.5
wildtype and Hectd1 mutant placentas showed no alterations in
expression levels. However, no staining is detected around the
central spiral arteries (csa in Fig. 4A and C) in mutants suggesting
that these cells are either not properly localized and/or speciﬁed.
By E12.5, Hand1 expression was markedly reduced throughout the
mutant placenta.
Multiple subtypes of terminally differentiated TGCs have been
reported based on gene expression, localization, morphology and
ploidy (Table 3 and Simmons et al., 2007). Parietal TGCs are
localized at the junctional zone forming a discontinuous border
between the maternal decidua and spongiotrophoblast layers.
These cells express Pl1, Pl2 and Plf. Spiral artery associated TGCs
express only Plf. Maternal blood canal associated TGCs express Pl2
and Plf but not Pl1. TGCs associated with the labyrinth layer
sinusoids express Pl2 but not Pl1 or Plf. Expression of these TGC
subtype markers was determined in E10.5 wildtype and Hectd1opm
homozygous mutant placentas by quantitative RT-PCR (qRT-PCR;
Fig. 4O). This analysis revealed signiﬁcant reductions in Pl1 and Plf
but not Pl2 levels in the mutant placenta at E10.5.
To examine alterations in the spatial expression of these
markers, in situ hybridization analyses was performed on placental
sections from E10.5 and 12.5 wildtype and Hectd1opm mutants
(Fig. 4E–N and summarized in Table 3). Pl1 is expressed at 10.5 but
not 12.5 and is unique to parietal TGCs (Simmons et al., 2007). In
the mutant placenta, Pl1 shows reduced and discontinuous
expression at the junctional zone (Fig. 4M and N). Consistent with
the qRT-PCR results, Pl2 expression levels were not altered in
mutants at E10.5 but Pl2-positive cells failed to localize around the
central spiral arteries (Fig. 4E and G, similar to the change seen in
Hand1 expression). By E12.5, Pl2 expression is reduced throughout
the junctional zone (Fig. 4F and H). Plf shows a reduced domain of
expression at E10.5; but by E12.5 its expression is expanded at the
junctional zone in Hectd1mutants (Fig. 4I–L). Taken together these
observations indicate that TGC subtypes are differentially and
dynamically affected in the Hectd1 mutant placenta.
Fig. 2. Hectd1 is expressed in multiple cell types throughout placental development. (A–L) Hectd1 expression in concepti or placentas (n¼8) at each of the indicated
stages fromwildtype females mated to Hectd1XC/þ males. This mating scheme resulted in LacZ staining in lineages derived from the conceptus but not the maternal decidua:
(A, B) at E7.5, Hectd1 is expressed in the primary and secondary TGCs and the extraembryonic lineages (ectoplacental cone; EPC and chorion) that contribute
to the mature placenta. Hectd1 is also expressed in the epiblast and amnion. (C, D) E8.5 Hectd1XC/þ conceptus showing widespread expression of Hectd1 with relatively
higher levels in the chorion and TGCs in the EPC. (E, F) E9.5 Hectd1XC/þ conceptus showing widespread expression of Hectd1 in the developing placenta with higher
levels in labyrinth trophoblasts at the border of the allantoic mesoderm (arrows in F) and scattered cells throughout the junctional zone (arrowheads in F). The layers of the
placenta are labeled: maternal decidua (MD), junctional zone (JZ), labyrinth zone (LZ) and allantoic mesoderm (AL). (G–L) E10.5 (G, H), E11.5 (I, J) and E12.5 (K, L) Hectd1XC/þ
placentas showing Hectd1 expression. Expression is markedly reduced in the allantoic mesoderm as compared to trophoblasts. High levels of expression are
found in labyrinth trophoblasts bordering the allantoic mesoderm (arrows in G) and trophoblasts scattered throughout the junctional zone (arrowhead in G–L). B, D, F,
H, J and L are magniﬁcations of boxed regions in A, C, E, G, I and K, respectively. (M, N) E13.5 Hectd1XC/þ placentas (n¼7) from Hectd1XC/þ intercrosses where expression
of Hectd1 is highlighted in both the maternal- and fetal-derived placental lineages. Intensity of Hectd1 expression is relatively greater in the maternal decidua than in fetal
trophoblast lineages where both maternal and fetal genotypes are Hectd1XC/þ . High levels of Hectd1 expression are found in cells lining large maternal arteries
(red *) and sinusoids (yellow *) in the junctional zone and maternal decidua. (N) In the labyrinth zone, Hectd1 is expressed at high levels in trophoblasts that
separate maternal (MBS) and fetal (FBS) blood spaces including ﬂat cells, which are likely syncytiotrophoblasts (arrows), but expression in the allantoic mesoderm is
comparatively less.
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Reduced spongiotrophoblasts in the junctional zone of Hectd1 mutant
placentas
To determine if Hectd1 is required for development of spongio-
trophoblasts and glycogen trophoblasts at the junctional zone,
expression of Tpbpa, Cdx2 and Mash2 was examined in E10.5 and
E12.5 placentas of wildtype and Hectd1opm homozygous mutants
(Fig. 5 and summarized in Table 3). At E10.5, Tpbpa is expressed in
spongiotrophoblasts and by E12.5 also in glycogen cells of the
junctional zone (Cross, 2005; Hu and Cross, 2011). Expression of
Tpbpawas decreased in Hectd1mutant placentas at both E10.5 and
E12.5. Moreover, at E12.5, Tpbpa expression, while detectible in the
labyrinth layer of mutants, was absent from the junctional zone
(Fig. 5B and D), demonstrating a reduction in the spongiotropho-
blasts and/or glycogen trophoblasts in this region. At E10.5 and
12.5, Cdx2 is expressed in spongiotrophoblasts of the junctional
zone (van Nes et al., 2006). In Hectd1 mutant placentas, the
expression domain as well as intensity of Cdx2 is reduced
(Fig. 5E–H). In addition, immunohistochemistry at E10.5 shows
reduced intensity of Cdx2 staining in the nuclei of spongiotropho-
blasts at the junctional zone as well as less cells expressing the
protein (Supplemental Fig. 3). Mash2 is expressed in spongiotro-
phoblasts in the junctional and labyrinth zones at E10.5 and 12.5
(Tanaka et al., 1997). In Hectd1 mutant placentas, the level of
Mash2 expression is not affected at E10.5 (Fig. 5I and K), but at
E12.5 expression of Mash2 is reduced (Fig. 5J and L). Taken
together, these results indicate that Hectd1 is required for devel-
opment of a subset of spongiotrophoblasts marked by Tpbpa,
Mash2 and Cdx2, particularly at the junctional zone.
Reduced glycogen trophoblasts in the junctional zone of Hectd1
mutant placentas
Glycogen trophoblasts differentiate from spongiotrophoblasts
forming islets with in the junctional zone and migrate into the
maternal decidua around E12.5 (Bouillot et al., 2006; Coan et al.,
2006). Tpbpa also marks glycogen trophoblasts and its reduction at
the junctional zone of E12.5 Hectd1 mutant placentas (Fig. 5A–D)
suggests a possible loss of this cell type. To determine if glycogen
trophoblasts are affected in the Hectd1 mutant placenta, the
glycogen content of E13.5 wildtype and mutant placentas was
determined by Periodic Acid-Schiff (PAS) staining on undigested
and amylase digested control placental sections (Fig. 6 and data
not shown). PAS staining is reduced in the maternal decidua,
junctional zone and scattered glycogen cell islets in the spongio-
trophoblast and labyrinth zones at E13.5 in Hectd1 mutants
(Fig. 6A–D). There is a signiﬁcant reduction in glycogen cell islets
in the junctional zone of Hectd1 mutant placentas (Fig. 6N).
Furthermore, biochemical quantiﬁcation of total glycogen content
in whole placentas shows a signiﬁcant decrease in Hectd1 mutants
at both E13.5 and E15.5 (Fig. 6M).
To determine if alterations in apoptosis could explain the
reduction of glycogen cell numbers in Hectd1opm mutant placentas,
apoptosis of these cells was examined. At E13.5, the total number
of cleaved caspase-3 positive cells were signiﬁcantly increased in
the mutant and clustered in the medial region of the decidua
(Fig. 6E–H and Supplemental Fig. 4). However, no difference in
apoptosis of glycogen containing cells was found between wild-
type and mutant samples (Fig. 6E–H, O). Thus increased apoptosis
is not likely responsible for the reduction in PAS positive cells
observed in the mutant placenta.
Altered uNK cell development in the Hectd1 mutant placenta
uNK cells of the maternal decidua are marked by high glycogen
content and undergo dramatic apoptosis after E12.5 (Bilinski et al.,
2008; Croy et al., 2003). uNK cells play an essential role in spiral
artery remodeling and promote TGC invasion around the spiral
arteries (Harris, 2010; Wallace et al., 2012). Since TGCs around the
central spiral arteries are decreased in Hectd1 mutants (Fig. 4), we
examined uNK cells as a possible underlying mechanism. The
maternal decidua of E13.5 mutant placentas showed a signiﬁcant
increase in uNK cells that co-label with PAS and the uNK marker
Perforin (Fig. 6I–L and P). However, these cells were smaller and
contained fewer cytoplasmic granules indicative of less mature
uNK cells (Fig. 6P). No difference in uNK cell numbers was noted in
the maternal decidua at E10.5 (Supplemental Fig. 5). Hence the
reduction in the glycogen content of the mutant placenta could be
attributed to both reduced number of glycogen islets in the
junctional zone and mature uNK cells in the maternal decidua.
Altered proliferation and apoptosis in the Hectd1 mutant placenta
To determine if proliferation is affected in Hectd1 mutant
placentas, the mitosis marker Phospho-Histone H3 was used. No
signiﬁcant differences in mitosis overall was observed in wildtype
versus Hectd1 mutant placentas at E12.5 (Fig. 7A and
Supplemental Fig. 6). Similarly, restricting the analysis to TGCs
did not show a signiﬁcant difference (Fig. 7B). Analysis of mitosis
in different placental layers shows an increase in the number of
mitotic cells in the maternal decidua, a decrease in the labyrinth
zone and no signiﬁcant difference in the junctional zone (Fig. 7C).
Apoptosis is increased in the Hectd1 mutant placenta (Fig. 6O).
To determine if regional speciﬁc differences are found, apoptotic
cells were counted in each layer of the placenta. This analysis
reveals a signiﬁcant difference in apoptotic cells in the maternal
decidua at E10.5 but not in the junctional or labyrinth zones
(Fig. 7D and Supplemental Fig. 4). At E13.5, apoptosis was
signiﬁcantly increased in both the labyrinth zone and maternal
decidua but not the junctional zone (Fig. 7E and Supplemental
Fig. 4). Since no change in junctional zone proliferation or
apoptosis was observed, alterations in TGC and spongiotrophoblast
populations in this region are not explained by disruption of cell
division or death. On the other hand, reduced proliferation and
increased apoptosis may account for the reduced thickness of the
labyrinth layer.
Discussion
Here, we describe a novel requirement for the E3 ubiquitin ligase
Hectd1 in placentation. Mutant placentas show reduced size and
Table 2
Summary of Hectd1 expression.
E7.5 E8.5 E9.5 E10.5 E11.5 E12.5 E13.5
EPC/TGCs þþ þþ þþ þþ þþ þþ þþ
Chorion/labyrinth trophoblasts þþ þþþ þþþ þþþ þþþ þþþ þþþ
Allantoic mesoderm þþ þþ þþ þ þ þ /þ
Maternal decidua ND ND ND ND ND þþþ þþþþ
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lamination of trophoblast-derived layers with a corresponding
increase in the thickness of the maternal decidua. Analysis of cell type
speciﬁc markers reveals defects in TGC development. Spongiotropho-
blasts and glycogen trophoblasts at the junctional zone are also
reduced. Finally, the numbers of immature uNK cells were increased.
Placental zone speciﬁc alterations in proliferation and apoptosis were
also identiﬁed. Namely, in the labyrinth zone proliferation was
decreased and apoptosis increased. In the maternal decidua both
proliferation and apoptosis was increased, while in the junctional zone
both were unchanged. Together these data demonstrate complex
changes in development of the Hectd1 mutant placenta. Placental
defects likely contribute to midgestation lethality and IUGR observed
in Hectd1 mutants. However, other causes of mid-gestation lethality
and IUGR also likely play an important role. For example, complex
cardiac defects have been reported in a different N-ethyl-N-
nitrosourea (ENU)-induced allele of Hectd1 (MGI:5313700). Since
alterations in cardiac function could exacerbate or even cause placen-
tal defects, additional experiments are required to determine if
placental abnormalities are due to cell autonomous defects in tropho-
blast development or are secondary to embryonic defects in Hectd1
mutants.
Hectd1 is highly expressed in scattered TGCs in the EPC that
contain progenitors for TGCs and TGC development is abnormal in
Hectd1 mutants. The number and nuclear size of TGCs is reduced
in Hectd1 mutants and altered expression and localization of TGC
markers are found in the mutant. In addition, TGCs migrate to
positions around the maternal central canal and medial spiral
arteries during decidualization. In the Hectd1 mutant placenta, the
lack of Hand1-, Pl1- and Pl2-expressing cells around the central
canal and spiral arteries suggests a possible requirement for
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Table 3
Summary of gene expression changes in Hectd1opm/opm placentas.
Marker Cell type E10.5 E12.5
HAND1 Trophoblast (E10.5); TGC, spongiotrophoblast, labyrinth trophoblast (E12.5) NC ↓↓↓
PL1 Parietal TGC ↓↓ N/A
PL2 Parietal TGC, canal and sinusoidal associated TGC NC ↓
Plf Spiral artery and canal associated TGC ↓ ↑↑↑
Tpbpa Spongiotrophoblast and glycogen trophoblasts ↓↓ ↓↓↓
Cdx2 Spongiotrophoblast ↓ ↓↓
Mash2 Spongiotrophoblast ↓ ↓↓
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counted in three placentas (NS: not signiﬁcant). Data represent the mean and error bars standard error of mean (SEM).
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Hectd1 in TGC invasion as well as differentiation. Additionally, the
number and morphology of uNK cells is altered and these play an
essential role in spiral artery remodeling.
The EPC also contains progenitors for spongiotrophoblasts and
glycogen trophoblasts, which are affected in Hectd1 mutant
placentas. The speciﬁc functions of these cells are not known;
but mouse mutants with defects in development of these cell
types show abnormal placentation (reviewed in Cross, 2005).
Multiple mouse mutants have documented defects in both cell
types suggesting common developmental programs (for example
Frank et al., 2002; Withington et al., 2006; Yang et al., 2003).
Signiﬁcant defects in development of both spongiotrophoblast and
glycogen trophoblast populations were found in the Hectd1
mutant placenta. Expression of Tpbpa, Cdx2 and Mash2 is reduced
at E12.5 in the junctional zone of Hectd1 mutant placenta. PAS
staining is reduced in mutant placental sections, as well as the
number of glycogen cell islets and the total glycogen content of the
placenta. Reduction of these cell-types could occur with altera-
tions in trophoblast differentiation, survival or proliferation. Since
neither apoptosis nor proliferation were affected in the junctional
zone of Hectd1 mutants, it is likely that Hectd1 is required for
differentiation of spongiotrophoblasts and glycogen trophoblasts.
The maternal decidua is also abnormal in Hectd1 mutants. The
decidua compartment of the Hectd1mutant placenta is larger with
respect to the other layers. Our data suggest that both apoptosis
and mitosis in the maternal decidual compartment is increased. In
addition, immature uNK cells are increased in numbers in the
mutant. uNK cells play an essential role in uterine vascular
remodeling, induce apoptosis in the decidualized uterus and are
themselves removed by cell death (Bilinski et al., 2008; Croy et al.,
2003; Harris, 2010; Wallace et al., 2012). Interestingly, the increase
of uNK cells in the decidua occurs coincident with an increase in
cleaved caspase-3 positive cells in the medial region of the
placenta. Together alterations in the invasive cell types (uNK cells,
glycogen trophoblasts, canal and spiral artery associated TGCs) in
the Hectd1 mutant placenta indicate a possible mis-regulation of
the coordination between the invasive trophoblasts and the
decidualizing maternal endometrial cells.
Hectd1 is highly expressed in the chorion and these cells
differentiate into labyrinth trophoblasts. This continued pattern
of expression in this lineage suggests a role for Hectd1 in devel-
opment of the labyrinth trophoblast. Hectd1 is an E3 ubiquitin
ligase that we have previously shown regulates total cellular
ubiquitination in the mouse embryo and embryonic ﬁbroblasts
(Sarkar and Zohn, 2012). Interestingly, while no obvious changes in
overall ubiquitination are found in the mutant placenta, the
presence of ubiquitin conjugates in labyrinth trophoblasts that
line maternal blood spaces is decreased in the mutant. The
requirement for Hectd1 in development of the labyrinth zone will
be further explored in another study where we show that Hectd1
mutant placentas have defects in branching morphogenesis in the
labyrinth zone. In addition, Hectd1 mutant placentas show com-
promised integrity of the endothelium that lines fetal vessels,
aberrant expression of labyrinth trophoblast markers and altered
allocation of trilaminar labyrinth trophoblast cell types (Sarkar and
Zohn, in preparation).
Placental defects in Hectd1 mutants show variable penetrance
and expressivity. This is common among placental defects (see
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Fig. 7. Cell proliferation and apoptosis are altered in the labyrinth zone and maternal decidua but not the junctional zone of Hectd1 mutant placentas. (A, B) Total Phospho-
Histone H3/mitotic cell numbers (A) or mitotic TGCs (B) do not differ signiﬁcantly between E12.5 wildtype (þ /þ) and Hectd1mutant (opm/opm) placentas. The total number
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counted in three placentas each. (D, E) Quantitation of cleaved caspase-3 positive cells in 10 random 200 μm2 frames each in three placentas. An increase in apoptotic cells
was found in the maternal decidua (MD) of Hectd1mutant (white bars) compared to wildtype (black bars) placenta at E10.5 (D) and the maternal decidua and labyrinth zone
(LZ) at E13.5 (E). No change in the number of apoptotic cells was found in the junctional zone (JZ) at either stage. Data represent mean values and error bars, standard error of
the mean (SEM).
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Barak et al., 2002; Caspary et al., 1999; Catela et al., 2009;
Eggenschwiler et al., 1997 for examples). Variable penetrance has
been attributed to a number of factors including genetic back-
ground, modiﬁer effects and environmental conditions (Barak et
al., 2008). However, our previous studies were done on a congenic
mouse line under relatively controlled environmental conditions.
On the other hand, there is inherent variability in placental
development possibly due to stochastic ﬂuctuations in gene
expression, epigenetic regulation, differentiation and morphogen-
esis that underlie development of the placenta (Coan et al., 2004;
Yuen and Robinson, 2011). One interesting hypothesis proposed to
explain how phenotypic variation is normally suppressed is that
molecular chaperones act to repress diversity (Ruden et al., 2003;
Yeyati and van Heyningen, 2008). Molecular chaperones, such as
heat shock proteins, assist in protein folding and have the
potential to buffer variations in gene function (Bergman and
Siegal, 2003; Queitsch et al., 2002; Rohner et al., 2013;
Rutherford and Lindquist, 1998; Sollars et al., 2003). Our studies
indicate that Hectd1 binds to and affects the function of Hsp90
(Sarkar and Zohn, 2012). Thus it is possible that altered Hsp90
function in Hectd1 mutants contributes to variable penetrance and
expressivity with respect to placental defects.
Known substrates of Hectd1 include heat shock protein 90
(Hsp90) and adenomatous polyposis coli (APC) involved in Wnt
signaling; both of which regulate placental development
(Sonderegger et al., 2010; Voss et al., 2000). Hsp90beta (Hsp90ab1)
mutants show defects in formation of the labyrinth layer due to a
requirement of Hsp90beta in the allantois for induction of tropho-
blast differentiation (Voss et al., 2000). Wnt signaling is required
at multiple steps in placentation including early determination of
trophoblast lineages and chorioallantoic fusion. However, with
regard to spongiotrophoblast, glycogen trophoblast, uNK and TGC
development, these mutant phenotypes differ signiﬁcantly from
Hectd1 mutants, suggesting Hsp90 and Wnt pathways are unlikely
to mediate all of these defects. Our ongoing studies to elucidate
the pathways regulated by Hectd1 indicate that the ubiquitination
of numerous substrates is affected in Hectd1 mutants (Li et al.,
2013; Sarkar and Zohn, 2012; Tran et al., 2013 and AAS and IEZ
unpublished). Since, multiple molecular pathways are implicated
in development of the placenta, the role of Hectd1 is likely very
complex.
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